查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1895152

药品批发和分销市场：2025-2035

Pharma Wholesale and Distribution Market Report 2025-2035
出版日期: | 出版商: Visiongain | 英文 303 Pages | 商品交期: 最快1-2个工作天内

价格

预计到2035年，全球药品批发和分销市场将以7.8%的复合年增长率成长。

冷炼是特种药品成长的核心：

药品批发和分销行业正在经历一场决定性的结构性变革。冷链不再是次要的物流环节，而是已成为该产业的核心策略基础。随着疫苗、生物製剂、细胞和基因疗法以及快速增长的GLP-1类药物等对温度敏感的产品在全球产品线中所占比例不断增加，批发商和分销商正在重新构想他们的战略，以满足对冷冻和冷藏存储、经过验证的包装系统以及大规模连续温度完整性监测日益增长的需求。

这一转变体现在2025年的两项重大公告中，这两项公告标誌着基础设施现代化进入了一个新阶段。 2025年3月，DHL宣布达成协议，收购美国生命科学物流专家CryoPDP，以增强其在生物製药、先进疗法和临床试验配送领域的温控能力。该公司2024年医疗保健业务收入达57亿美元，此举凸显了其致力于透过整合端到端平台引领全球冷链物流的决心。 2025年11月5日，Cencora宣布了一项突破性的10亿美元投资计划，旨在到2030年改造其美国药品配送网络。该计画包括在俄亥俄州哈里森新建一座53万平方英尺的全国配送中心，以及在加州和阿拉巴马州进行大规模扩建。这些新一代配送中心将整合先进的仓库自动化系统、机器人拣选系统以及显着提升的冷藏和冷冻储存能力，以支援日益增长的特殊药品配送需求。

这些发展标誌着医药批发和分销生态系统的重要转折点。成长最快的治疗领域——肿瘤药物、生物製剂、疫苗和GLP-1疗法——需要高度可靠的冷链管理和精准处理。 Cencora的投资重新定义了竞争优势。批发商现在必须成为冷链、自动化和数据驱动型物流专家，而不仅仅是供应链中间商。

从品牌药和仿製药分销商到疫苗、生物製药和医疗器材管道，所有细分市场都受到了影响。与高性能温控物流合作伙伴进行策略合作，或发展同等程度的内部能力，正成为获得全国性合约、机构投标和与製造商建立长期合作关係的先决条件。

随着冷链逐渐成为关键资产，市场领导者将凭藉其在日益复杂的产品组合中提供温控完整性、营运韧性和技术赋能的卓越分销能力而脱颖而出。

本报告分析了全球药品批发和分销市场，并提供了市场概览、市场成长因素和市场机会分析、市场规模趋势和预测、按细分市场、地区和主要国家/地区进行的详细分析、竞争格局以及主要公司简介。

目录

第一章：报告概述

第二章：摘要整理

第三章：市场概览

  • 主要发现
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机遇
  • 美国关税：对全球药品批发和分销市场的影响
  • 波特五力分析
  • PEST分析

第四章 药品批发和分销市场分析：按类型划分

  • 主要发现
  • 市场吸引力指数
  • 市场规模估算与预测
  • 批发商
    • 按地区划分的市场规模
    • 按地区划分的市场占有率
    • 按类型划分的市场规模
    • 生产商批发商
    • 商业批发商
    • 代理商和经纪人
  • 经销商
    • 按地区划分的市场规模
    • 按地区划分的市场占有率
    • 按类型划分的市场规模
    • 单一经销商
    • 多方经销商

第五章 药品批发及分销市场分析：依分销类型划分

  • 主要发现
  • 市场吸引力指数
  • 市场规模估算与预测
  • 品牌药/处方药分销商
  • 仿製药经销商
  • PCD特许经营
  • 非处方药/机构供应药品分销商
  • 其他
    • 市场规模趋势与预测：按地区划分
    • 市占率历史资料与预测：按地区划分

第六章 药品批发及分销市场分析：依产品类型划分

  • 主要发现
  • 市场吸引力指数
  • 市场规模估算与预测
  • 品牌药
  • 仿製药
  • 非处方药
  • 医疗器材
  • 疫苗
  • 其他
    • 市场规模趋势与预测：按地区划分
    • 市占率表现与预测：按地区划分

第七章：药品批发和分销市场分析：按最终用户

  • 主要发现
  • 市场吸引力指数
  • 市场规模估算与预测
  • 医院和诊所
  • 零售药局
  • 线上药局
  • 其他
    • 市场规模趋势与预测：按地区划分
    • 市占率表现与预测：按地区划分

第八章：药品批发和分销市场分析：按地区划分

  • 主要发现
  • 市场规模趋势与预测：按地区划分

第九章：北美药品批发和分销市场分析

  • 主要发现
  • 市场吸引力指数
  • 各国市场规模：2025年、2030年2035
  • 市场规模估计与预测：依国家划分
  • 市场规模估算与预测：依类型划分
  • 市场规模估算与预测：依分销类型划分
  • 市场规模估算与预测：依产品类型划分
  • 市场规模估算与预测：依最终用户划分
  • 美国
  • 加拿大

第十章 欧洲药品批发与配销市场分析

  • 主要发现
  • 市场吸引力指数
  • 依国家划分的市场规模：2025年、2030年、2035年
  • 市场估计与预测：依国家划分
  • 市场估计与预测：依类型划分
  • 市场估计与预测：依分销类型划分
  • 市场估算与预测：依产品类型划分类型
  • 市场估计与预测：依最终用户划分
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他

第十一章 亚太地区药品批发与分销市场分析

  • 主要发现
  • 市场吸引力指数
  • 各国市场规模：2025年、2030年、2035年
  • 市场估计与预测：依国家划分
  • 市场估计与预测：依类型划分
  • 市场估计与预测：依分销类型划分
  • 市场估算与预测：依产品类型划分
  • 市场估计与预测：依最终用户划分用户
  • 日本
  • 中国
  • 印度
  • 澳大利亚
  • 韩国
  • 东南亚
  • 其他

第十二章 拉丁美洲药品批发及配销市场分析

  • 主要发现
  • 市场吸引力指数
  • 依国家划分的市场规模：2025年、2030年、2035年
  • 按国家/地区划分的市场估计和预测
  • 按类型划分的市场估算与预测
  • 按分销类型划分的市场估算与预测
  • 依产品类型划分的市场估算与预测
  • 按最终用户划分的市场估算与预测用户
  • 巴西
  • 墨西哥
  • 阿根廷
  • 哥伦比亚
  • 其他

第十三章 中东及非洲药品批发及配销市场分析

  • 主要发现
  • 市场吸引力指数
  • 依国家划分的市场规模：2025年、2030年、2035年
  • 按国家/地区划分的市场估计和预测
  • 按类型划分的市场估算与预测
  • 按分销类型划分的市场估算与预测
  • 依产品类型划分的市场估算与预测
  • 按最终用户划分的市场估算和预测
  • 海湾合作委员会国家
  • 南非
  • 其他

第十四章：公司简介

  • Cencora,公司
  • Cardinal Health, Inc.
  • CuraScript, Inc.
  • Dakota Drug, Inc.
  • Fortissa
  • Geo-Young Co., Ltd.
  • Kingworld Medicines Group Limited
  • Mckesson Corporation
  • Medipal Holdings Corporation
  • Mutual Drug
  • Petrone Group
  • Prodigy Health LLC
  • Sinopharm Group Co. Ltd.
  • Smith Drug Co., Inc.
  • Walgreens Boots Alliance, Inc.

第十五章 结论与建议

  • Visiongain 的结论
  • 对参与者的建议
Product Code: PHA1377

The global Pharma Wholesale and Distribution market is projected to grow at a CAGR of 7.8% by 2035.

The Pharma Wholesale and Distribution Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Cold Chain Positions Itself as the Core of Specialty Pharma Growth

The pharmaceutical wholesale and distribution landscape is undergoing a decisive structural shift: cold chain is no longer a supportive logistics layerit has become the industry's core strategic backbone. With an expanding share of global pipelines centred on temperature-sensitive productsincluding vaccines, biologics, cell- and gene-based therapies, and the accelerating GLP-1 classwholesalers and distributors are realigning their strategies according to the growing demand for frozen and refrigerated storage, validated packaging systems, and continuous temperature-integrity monitoring at scale.

This shift is reflected in two major 2025 announcements signalling a new phase of infrastructure modernisation. In March 2025, DHL confirmed its agreement to acquire U.S. life-science logistics specialist CryoPDP, strengthening its temperature-controlled capabilities across biopharma, advanced therapies and clinical-trial distribution. The move builds on the company's US$5.7 billion healthcare revenues in 2024, underscoring its ambition to lead global cold-chain logistics through integrated, end-to-end platforms.

On 5 November 2025, Cencora unveiled a landmark US$1 billion investment programme aimed at transforming its U.S. pharmaceutical distribution network through 2030. The initiative includes construction of a new 530,000 sq. ft national distribution centre in Harrison, Ohio, alongside major expansions in California and Alabama. These next-generation hubs will integrate advanced warehouse automation, robotic picking systems and significantly enhanced refrigerated and frozen storage capacity to support the rising flow of specialty pharmaceuticals.

For the pharma wholesale and distribution ecosystem, these developments mark a critical inflection point. The fastest-expanding therapeutic categoriesoncology drugs, biologics, vaccines, and GLP-1 therapiesdemand ultra-reliable cold-chain control and precision handling. Cencora's investment signals a recalibration of competitive advantage: wholesalers must now operate as cold-chain, automation and data-driven fulfilment specialists, not merely intermediaries in the supply chain.

The implications are clear for all players across your segmentationfrom branded and generic pharmaceutical distributors to vaccine, biologics, and medical-device channels. Strategic alignment with high-performance temperature-controlled logistics partnersor the development of internal capabilities of comparable scaleis rapidly becoming a prerequisite to securing national contracts, institutional tenders and long-term manufacturer partnerships.

As cold chain transitions into a mission-critical asset, market leaders will be defined by their ability to deliver temperature-integrity, operational resilience and technology-enabled distribution excellence across increasingly complex product portfolios.

What would be the Impact of US Trade Tariffs on the Global Pharma Wholesale and Distribution Market?

U.S. trade tariffs can significantly disrupt global pharmaceutical wholesale and distribution by increasing import costs for APIs, finished drugs, packaging materials and medical devices sourced from China, India and Europe. Higher landed costs compress distributor margins and may trigger price adjustments across branded, generic and OTC channels. Tariffs also slow cross-border flow times, forcing wholesalers to hold larger safety stocks and invest more in working capital. For multi-party distributors and PCD/institutional suppliers, tariff volatility increases procurement risk and complicates contracting with manufacturers. Ultimately, tariffs create cost instability, supply uncertainty and operational pressure across the entire distribution ecosystem.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Pharma Wholesale and Distribution market evolving?
  • What is driving and restraining the Pharma Wholesale and Distribution market?
  • How will each Pharma Wholesale and Distribution submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each Pharma Wholesale and Distribution submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading Pharma Wholesale and Distribution markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the Pharma Wholesale and Distribution projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035? What are the implications of
  • Pharma Wholesale and Distribution projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the Pharma Wholesale and Distribution market?
  • Where is the Pharma Wholesale and Distribution market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Pharma Wholesale and Distribution market today, and over the next 10 years:

  • Visiongain's 303-page report provides 112 tables and 158 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
  • Forecasts to 2035 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

  • Type
  • Wholesalers
  • Producer Wholesaler
  • Merchant Wholesaler
  • Agents and Brokers
  • Distributor
  • Single Party Distributor
  • Multi Party Distributor
  • Distribution Type
  • Ethical/Branded Pharma Products Distributors
  • Generic Pharma Products Distributors
  • Propaganda Cum Distribution (PCD) Franchise
  • OTC/Institutional Supply Pharma Distributors
  • Others
  • Product Type
  • Branded Pharmaceuticals
  • Generic Pharmaceuticals
  • Over-the-counter (OTC) Pharmaceuticals
  • Vaccines
  • Medical Devices
  • Others
  • End-users
  • Hospitals & Clinics
  • Retail Pharmacies
  • Online / E-Pharmacies
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South-East Asia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America
  • MEA
  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles for some of the leading companies in the Pharma Wholesale and Distribution Market, 2025 to 2035, with a focus on this segment of these companies' operations.

  • Leading companies and the potential for market growth
  • AmerisourceBergen Corporation
  • Cardinal Health, Inc.
  • CuraScript, Inc.
  • Dakota Drug, Inc.
  • Fortissa
  • Geo-Young Co., Ltd.
  • Kingworld Medicines Group Limited
  • Mckesson Corporation
  • Medipal Holdings Corporation
  • Mutual Drug
  • Petrone Group
  • Prodigy Health LLC
  • Sinopharm Group Co. Ltd.
  • Smith Drug Co., Inc.
  • Walgreens Boots Alliance, Inc.

Overall world revenue for Pharma Wholesale and Distribution Market, 2025 to 2035 in terms of value the market will surpass US$ 1,033.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

  • How will the Pharma Wholesale and Distribution Market, 2025 to 2035 report help you?
  • In summary, our 300+ page report provides you with the following knowledge:
  • Revenue forecasts to 2035 for Pharma Wholesale and Distribution Market 2025 to 2035, with forecasts for type, distribution type, product type, and end-users, each forecast at a global and regional level discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 24 key national markets See forecasts for the Pharma Wholesale and Distribution Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market including company profiles for 15 of the major companies involved in the Pharma Wholesale and Distribution Market, 2025 to 2035.
  • Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Pharma Wholesale and Distribution Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Rising Demand for Prescription and OTC Drugs
      • 3.2.1.2 Healthcare Infrastructure Expansion
      • 3.2.1.3 Regulatory Compliance and Safety Requirements
      • 3.2.1.4 Shift Towards Specialty Drugs and Biologics
      • 3.2.1.5 Growing Global Pharmaceutical Sales
      • 3.2.1.6 Rising Seaborne Pharmaceutical Transportation
      • 3.2.1.7 Automation and Digitalization Driving Industry Growth
      • 3.2.1.8 Implementation of Track and Trace Solutions
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Stringent Regulations Imposed by Government
      • 3.2.2.2 Price Pressures Likely to Challenge Market Growth
      • 3.2.2.3 Rise in Pharmaceutical Counterfeiting
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Specializing in Niche Drugs and Therapies
      • 3.2.3.2 Embracing E-commerce and Digital Technologies
      • 3.2.3.3 Focusing on Sustainability and Ethical Sourcing
      • 3.2.3.4 Implementation of AI in Pharmaceutical Supply Chain
  • 3.3 U.S. Tariffs: What's the Impact on Global Pharma Wholesale and Distribution Market?
    • 3.3.1 Overview
    • 3.3.2 V-Shaped Recovery Scenario
    • 3.3.3 Why V-Shaped Recovery?
      • 3.3.3.1 Impact from Tariffs
      • 3.3.3.2 Market Dynamics and Demand Recovery
      • 3.3.3.3 Policy and Funding Support
      • 3.3.3.4 Timeframe for Recovery
    • 3.3.4 U-Shaped Recovery Scenario
      • 3.3.4.1 Why U-Shaped Recovery?
      • 3.3.4.2 Impact from Tariffs
      • 3.3.4.3 Market Dynamics and Demand Recovery
      • 3.3.4.4 Policy and Funding Support
      • 3.3.4.5 Timeframe for Recovery
    • 3.3.5 L Shaped Recovery Scenario
      • 3.3.5.1 Why L-Shaped Recovery?
      • 3.3.5.2 Impact from Tariffs
      • 3.3.5.3 Market Dynamics and Demand Recovery
      • 3.3.5.4 Policy and Funding Support
      • 3.3.5.5 Timeframe for Recovery
    • 3.3.6 What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
    • 3.3.7 Impact of U.S. and China Trade War on Pharma Wholesale and Distribution Market
    • 3.3.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat of Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Pharma Wholesale and Distribution Market Analysis by Type

  • 4.1 Key Findings
  • 4.2 Type Segment: Market Attractiveness Index
  • 4.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 4.4 Wholesalers
    • 4.4.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 4.4.2 Market Share by Region, 2025 & 2035 (%)
    • 4.4.3 Market Size by Type, 2025-2035 (US$ Billion)
    • 4.4.4 Producer Wholesaler
    • 4.4.5 Merchant Wholesaler
    • 4.4.6 Agents and Brokers
  • 4.5 Distributor
    • 4.5.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 4.5.2 Market Share by Region, 2025 & 2035 (%)
    • 4.5.3 Market Size by Type, 2025-2035 (US$ Billion)
    • 4.5.4 Single Party Distributor
    • 4.5.5 Multi Party Distributor

5 Pharma Wholesale and Distribution Market Analysis by Distribution Type

  • 5.1 Key Findings
  • 5.2 Distribution Type Segment: Market Attractiveness Index
  • 5.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 5.4 Ethical/Branded Pharma Products Distributors
    • 5.4.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.4.2 Market Share by Region, 2025 & 2035 (%)
  • 5.5 Generic Pharma Products Distributors
    • 5.5.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.5.2 Market Share by Region, 2025 & 2035 (%)
  • 5.6 Propaganda Cum Distribution (PCD) Franchise
    • 5.6.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.6.2 Market Share by Region, 2025 & 2035 (%)
  • 5.7 OTC/Institutional Supply Pharma Distributors
    • 5.7.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.7.2 Market Share by Region, 2025 & 2035 (%)
  • 5.8 Others
    • 5.8.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.8.2 Market Share by Region, 2025 & 2035 (%)

6 Pharma Wholesale and Distribution Market Analysis by Product Type

  • 6.1 Key Findings
  • 6.2 Product Type Segment: Market Attractiveness Index
  • 6.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 6.4 Branded Pharmaceuticals
    • 6.4.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.4.2 Market Share by Region, 2025 & 2035 (%)
  • 6.5 Generic Pharmaceuticals
    • 6.5.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.5.2 Market Share by Region, 2025 & 2035 (%)
  • 6.6 Over-the-counter (OTC) Pharmaceuticals
    • 6.6.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.6.2 Market Share by Region, 2025 & 2035 (%)
  • 6.7 Medical Devices
    • 6.7.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.7.2 Market Share by Region, 2025 & 2035 (%)
  • 6.8 Vaccines
    • 6.8.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.8.2 Market Share by Region, 2025 & 2035 (%)
  • 6.9 Others
    • 6.9.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.9.2 Market Share by Region, 2025 & 2035 (%)

7 Pharma Wholesale and Distribution Market Analysis by End-users

  • 7.1 Key Findings
  • 7.2 End-users Segment: Market Attractiveness Index
  • 7.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
  • 7.4 Hospitals and Clinics
    • 7.4.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 7.4.2 Market Share by Region, 2025 & 2035 (%)
  • 7.5 Retail Pharmacies
    • 7.5.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 7.5.2 Market Share by Region, 2025 & 2035 (%)
  • 7.6 Online / E-Pharmacies
    • 7.6.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 7.6.2 Market Share by Region, 2025 & 2035 (%)
  • 7.7 Others
    • 7.7.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 7.7.2 Market Share by Region, 2025 & 2035 (%)

8 Pharma Wholesale and Distribution Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America Pharma Wholesale and Distribution Market Analysis

  • 9.1 Key Findings
  • 9.2 North America Pharma Wholesale and Distribution Market Attractiveness Index
  • 9.3 North America Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 9.4 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 9.5 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 9.6 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 9.7 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 9.8 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
  • 9.9 U.S. Pharma Wholesale and Distribution Market Analysis
  • 9.10 Canada Pharma Wholesale and Distribution Market Analysis

10 Europe Pharma Wholesale and Distribution Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe Pharma Wholesale and Distribution Market Attractiveness Index
  • 10.3 Europe Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 10.4 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 10.5 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 10.6 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 10.7 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 10.8 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
  • 10.9 Germany Pharma Wholesale and Distribution Market Analysis
  • 10.10 France Pharma Wholesale and Distribution Market Analysis
  • 10.11 UK Pharma Wholesale and Distribution Market Analysis
  • 10.12 Italy Pharma Wholesale and Distribution Market Analysis
  • 10.13 Spain Pharma Wholesale and Distribution Market Analysis
  • 10.14 Russia Pharma Wholesale and Distribution Market Analysis
  • 10.15 Rest of Europe Pharma Wholesale and Distribution Market Analysis

11 Asia Pacific Pharma Wholesale and Distribution Market analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific Pharma Wholesale and Distribution Market Attractiveness Index
  • 11.3 Asia Pacific Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 11.4 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 11.5 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 11.6 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 11.7 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 11.8 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
  • 11.9 Japan Pharma Wholesale and Distribution Market Analysis
  • 11.10 China Pharma Wholesale and Distribution Market Analysis
  • 11.11 India Pharma Wholesale and Distribution Market Analysis
  • 11.12 Australia Pharma Wholesale and Distribution Market Analysis
  • 11.13 South Korea Pharma Wholesale and Distribution Market Analysis
  • 11.14 South-East Asia Pharma Wholesale and Distribution Market Analysis
  • 11.15 Rest of Asia Pacific Pharma Wholesale and Distribution Market Analysis

12 Latin America Pharma Wholesale and Distribution Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America Pharma Wholesale and Distribution Market Attractiveness Index
  • 12.3 Latin America Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 12.4 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 12.5 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 12.6 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 12.7 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 12.8 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
  • 12.9 Brazil Pharma Wholesale and Distribution Market Analysis
  • 12.10 Mexico Pharma Wholesale and Distribution Market Analysis
  • 12.11 Argentina Pharma Wholesale and Distribution Market Analysis
  • 12.12 Colombia Pharma Wholesale and Distribution Market Analysis
  • 12.13 Rest of Latin America Pharma Wholesale and Distribution Market Analysis

13 MEA Pharma Wholesale and Distribution Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA Pharma Wholesale and Distribution Market Attractiveness Index
  • 13.3 MEA Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 13.4 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 13.5 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 13.6 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 13.7 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 13.8 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
  • 13.9 GCC Pharma Wholesale and Distribution Market Analysis
  • 13.10 South Africa Pharma Wholesale and Distribution Market Analysis
  • 13.11 Rest of MEA Pharma Wholesale and Distribution Market Analysis

14 Company Profiles

  • 14.1 Cencora, Inc.
    • 14.1.1 Company Snapshot
    • 14.1.2 Company Overview
    • 14.1.3 Financial Analysis
      • 14.1.3.1 Net Revenue, 2020-2024
      • 14.1.3.2 Regional Market Shares, 2024
    • 14.1.4 Service Benchmarking
    • 14.1.5 Strategic Outlook
  • 14.2 Cardinal Health, Inc.
    • 14.2.1 Company Snapshot
    • 14.2.2 Company Overview
    • 14.2.3 Financial Analysis
      • 14.2.3.1 Net Revenue, 2020-2024
      • 14.2.3.2 Regional Market Shares, 2024
    • 14.2.4 Service Benchmarking
    • 14.2.5 Strategic Outlook
  • 14.3 CuraScript, Inc.
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Service Benchmarking
  • 14.4 Dakota Drug, Inc.
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Service Benchmarking
  • 14.5 Fortissa
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Service Benchmarking
  • 14.6 Geo-Young Co., Ltd.
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Service Benchmarking
  • 14.7 Kingworld Medicines Group Limited
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Service Benchmarking
  • 14.8 Mckesson Corporation
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis
      • 14.8.3.1 Net Revenue, 2020-2024
      • 14.8.3.2 Regional Market Shares, 2024
    • 14.8.4 Service Benchmarking
    • 14.8.5 Strategic Outlook
  • 14.9 Medipal Holdings Corporation
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Financial Analysis
      • 14.9.3.1 Net Revenue, 2017-2022
    • 14.9.4 Service Benchmarking
  • 14.10 Mutual Drug
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Service Benchmarking
  • 14.11 Petrone Group
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Service Benchmarking
    • 14.11.4 Strategic Outlook
  • 14.12 Prodigy Health LLC
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Service Benchmarking
  • 14.13 Sinopharm Group Co. Ltd.
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Financial Analysis
      • 14.13.3.1 Net Revenue, 2017-2022
    • 14.13.4 Service Benchmarking
  • 14.14 Smith Drug Co., Inc.
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Service Benchmarking
  • 14.15 Walgreens Boots Alliance, Inc.
    • 14.15.1 Company Snapshot
    • 14.15.2 Company Overview
    • 14.15.3 Financial Analysis
      • 14.15.3.1 Net Revenue, 2017-2022
    • 14.15.4 Service Benchmarking
    • 14.15.5 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from Visiongain
  • 15.2 Recommendations for Market Players

List of Tables

  • Table 1 Pharma Wholesale and Distribution Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
  • Table 2 Pharma Wholesale and Distribution Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Pharma Wholesale and Distribution Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Pharma Wholesale and Distribution Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 5 Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 6 Wholesalers Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 7 Wholesaler Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 8 Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 9 Distributor Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 10 Pharma Wholesale and Distribution Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 11 Ethical/Branded Pharma Product Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 12 Generic Pharma Product Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 13 Propaganda Cum Distribution (PCD) Franchise Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 14 OTC/Institutional Supply Pharma Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 15 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 16 Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 17 Branded Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 18 Generic Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 19 Over-the-counter (OTC) Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 20 Medical Devices Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 21 Vaccines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 22 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 23 Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 24 Hospitals & Clinics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 25 Retail Pharmacies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 26 Online / E-Pharmacies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 27 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 28 Pharma Wholesale and Distribution Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 29 North America Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 30 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 31 North America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 32 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 33 North America Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 34 U.S. Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 35 Canada Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 36 Europe Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 37 Europe Pharma Wholesale and Distribution Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 38 Europe Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 39 Europe Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 40 Europe Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 41 Germany Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 42 France Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 43 UK Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 44 Italy Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 45 Spain Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 46 Russia Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 47 Rest of Europe Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 48 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 49 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 50 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 51 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 52 Asia Pacific Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 53 Japan Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 54 China Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 55 India Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 56 Australia Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 57 South Korea Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 58 South-East Asia Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 59 Rest of Asia Pacific Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 60 Latin America Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 61 Latin America Pharma Wholesale and Distribution Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 62 Latin America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 63 Latin America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 64 Latin America Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 65 Brazil Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 66 Mexico Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 67 Argentina Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 68 Colombia Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 69 Rest of Latin America Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 70 MEA Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 71 MEA Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 72 MEA Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 73 MEA Pharma Wholesale and Distribution Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 74 MEA Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 75 GCC Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 76 South Africa Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 77 Rest of MEA Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 78 Cencora, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 79 Cencora, Inc.: Service Benchmarking
  • Table 80 Cencora, Inc.: Strategic Outlook
  • Table 81 Cardinal Health, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 82 Cardinal Health, Inc.: Service Benchmarking
  • Table 83 Cardinal Health, Inc.: Strategic Outlook
  • Table 84 CuraScript, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 CuraScript, Inc.: Service Benchmarking
  • Table 86 Dakota Drug, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 87 Dakota Drug, Inc.: Service Benchmarking
  • Table 88 Fortissa: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 89 Fortissa: Service Benchmarking
  • Table 90 Geo-Young Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 Geo-Young Co., Ltd.: Service Benchmarking
  • Table 92 Kingworld Medicines Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 93 Kingworld Medicines Group Limited: Service Benchmarking
  • Table 94 Mckesson Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 95 Mckesson Corporation: Service Benchmarking
  • Table 96 Mckesson Corporation: Strategic Outlook
  • Table 97 Medipal Holdings Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 Medipal Holdings Corporation: Service Benchmarking
  • Table 99 Mutual Drug: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 100 Mutual Drug: Service Benchmarking
  • Table 101 Petrone Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Petrone Group: Service Benchmarking
  • Table 103 Petrone Group: Strategic Outlook
  • Table 104 Prodigy Health LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 105 Prodigy Health LLC: Service Benchmarking
  • Table 106 Sinopharm Group Co. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Sinopharm Group Co. Ltd.: Service Benchmarking
  • Table 108 Smith Drug Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 Smith Drug Co., Inc.: Service Benchmarking
  • Table 110 Walgreens Boots Alliance, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 Walgreens Boots Alliance, Inc.: Service Benchmarking
  • Table 112 Walgreens Boots Alliance, Inc.: Strategic Outlook

List of Figures

  • Figure 1 Pharma Wholesale and Distribution Market Segmentation
  • Figure 2 Pharma Wholesale and Distribution Market by Type: Market Attractiveness Index
  • Figure 3 Pharma Wholesale and Distribution Market by Distribution Type: Market Attractiveness Index
  • Figure 4 Pharma Wholesale and Distribution Market by Product Type: Market Attractiveness Index
  • Figure 5 Pharma Wholesale and Distribution Market Attractiveness Index by Region
  • Figure 6 Pharma Wholesale and Distribution Market: Market Dynamics
  • Figure 7 Pharma Wholesale and Distribution Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
  • Figure 8 Pharma Wholesale and Distribution Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
  • Figure 9 Pharma Wholesale and Distribution Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
  • Figure 10 Short Term & Long-Term Planning
  • Figure 11 Impact of U.S. and China Trade War
  • Figure 12 Most Impacted Countries
  • Figure 13 Pharma Wholesale and Distribution Market: Porter's Five Forces Analysis
  • Figure 14 Pharma Wholesale and Distribution Market: PEST Analysis
  • Figure 15 Pharma Wholesale and Distribution Market by Type: Market Attractiveness Index
  • Figure 16 Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 17 Pharma Wholesale and Distribution Market Share Forecast by Type, 2025, 2030, 2035 (%)
  • Figure 18 Wholesalers Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 19 Wholesalers Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 20 Wholesalers Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 21 Distributor Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 22 Distributor Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 23 Distributors Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 24 Pharma Wholesale and Distribution Market by Distribution Type: Market Attractiveness Index
  • Figure 25 Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 26 Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025, 2030, 2035 (%)
  • Figure 27 Ethical/Branded Pharma Products Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 28 Ethical/Branded Pharma Products Distributors Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 29 Generic Pharma Products Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 30 Generic Pharma Products Distributors Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 31 Propaganda Cum Distribution (PCD) Franchise Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 32 Propaganda Cum Distribution (PCD) Franchise Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 33 OTC/Institutional Supply Pharma Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 34 OTC/Institutional Supply Pharma Distributors Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 35 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 36 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 37 Pharma Wholesale and Distribution Market by Product Type: Market Attractiveness Index
  • Figure 38 Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 39 Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025, 2030, 2035 (%)
  • Figure 40 Branded Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 41 Branded Pharmaceuticals Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 42 Generic Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 43 Generic Pharmaceuticals Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 44 Over-the-counter (OTC) Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 45 Over-the-counter (OTC) Pharmaceuticals Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 46 Medical Devices Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 47 Medical Devices Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 48 Vaccines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 49 Vaccines Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 50 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 51 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 52 Pharma Wholesale and Distribution Market by End-users: Market Attractiveness Index
  • Figure 53 Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 54 Pharma Wholesale and Distribution Market Share Forecast by End-users, 2025, 2030, 2035 (%)
  • Figure 55 Hospitals and Clinics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 56 Hospitals and Clinics Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 57 Retail Pharmacies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 58 Retail Pharmacies Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 59 Online / E-Pharmacies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 60 Online / E-Pharmacies Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 61 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 62 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 63 Pharma Wholesale and Distribution Market Forecast by Region 2025 and 2035, (Revenue, CAGR%)
  • Figure 64 Pharma Wholesale and Distribution Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 65 Pharma Wholesale and Distribution Market by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 66 North America Pharma Wholesale and Distribution Market Attractiveness Index
  • Figure 67 North America Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 68 North America Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 69 North America Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 70 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 71 North America Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 72 North America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 73 North America Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025 & 2035 (%)
  • Figure 74 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 75 North America Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 76 North America Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 77 North America Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
  • Figure 78 U.S. Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 79 Canada Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 80 Europe Pharma Wholesale and Distribution Market Attractiveness Index
  • Figure 81 Europe Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 82 Europe Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 83 Europe Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 84 Europe Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 85 Europe Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 86 Europe Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 87 Europe Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025 & 2035 (%)
  • Figure 88 Europe Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR.%)
  • Figure 89 Europe Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 90 Europe Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 91 Europe Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
  • Figure 92 Germany Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 93 France Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 94 UK Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 95 Italy Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 96 Spain Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 97 Russia Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 98 Rest of Europe Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 99 Asia Pacific Pharma Wholesale and Distribution Market Attractiveness Index
  • Figure 100 Asia Pacific Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 101 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 102 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 103 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 104 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2035 (%)
  • Figure 105 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Distribution Type, .2025-2035 (US$ Billion, AGR %)
  • Figure 106 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Distribution .Type, 2025 & 2035 (%)
  • Figure 107 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Product Type, .2025-2035 (US$ Billion, AGR %)
  • Figure 108 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Product .Type, 2025 & 2035 (%)
  • Figure 109 Asia Pacific Pharma Wholesale and Distribution Market Forecast by End-users, .2025-2035 (US$ Billion, AGR %)
  • Figure 110 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
  • Figure 111 Japan Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 112 China Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 113 India Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 114 Australia Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 115 South Korea Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 116 South-East Asia Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 117 Rest of Asia Pacific Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 118 Latin America Pharma Wholesale and Distribution Market Attractiveness Index
  • Figure 119 Latin America Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 120 Latin America Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 121 Latin America Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 122 Latin America Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 123 Latin America Pharma Wholesale and Distribution Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 124 Latin America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 125 Latin America Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025 & 2035 (%)
  • Figure 126 Latin America Pharma Wholesale and Distribution Market Forecast by Product Type, (US$ Billion, AGR %)
  • Figure 127 Latin America Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 128 Latin America Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 129 Latin America Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
  • Figure 130 Brazil Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 131 Mexico Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 132 Argentina Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 133 Colombia Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 134 Rest of Latin America Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 135 MEA Pharma Wholesale and Distribution Market Attractiveness Index
  • Figure 136 MEA Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 137 MEA Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 138 MEA Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 139 MEA Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 140 MEA Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 141 MEA Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 142 MEA Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025 & 2035 (%)
  • Figure 143 MEA Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 144 MEA Pharma Wholesale and Distribution Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 145 MEA Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 146 MEA Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
  • Figure 147 GCC Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 148 South Africa Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 149 Rest of MEA Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 150 Cencora, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 151 Cencora, Inc.: Regional Market Shares, 2024
  • Figure 152 Cardinal Health, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 153 Cardinal Health, Inc.: Regional Market Shares, 2024
  • Figure 154 Mckesson Corporation: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 155 Mckesson Corporation: Regional Market Shares, 2024
  • Figure 156 Medipal Holdings Corporation: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 157 Sinopharm Group Co. Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 158 Walgreens Boots Alliance, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR %)